Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study (2024) Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath M, et al. Journal article Unklarer Bauch: Eine therapeutische Herausforderung (2024) Atreya R Journal article Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells (2024) Wiendl M, Dedden M, Liu L, Schweda A, Paap EM, Ullrich K, Hartmann L, et al. Journal article p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer (2024) Thoma OM, Naschberger E, Kubánková M, Larafa I, Kramer V, Menchicchi B, Merkel S, et al. Journal article Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis (2024) Vitali F, Rath T, Klenske E, Vögele AL, Ganzleben I, Zundler S, Strobel D, et al. Journal article Myenteric Plexus Immune Cell Infiltrations and Neurotransmitter Expression in Crohn’s Disease and Ulcerative Colitis (2024) Wiese JJ, Manna S, Kühl AA, Fascì A, Elezkurtaj S, Sonnenberg E, Bubeck M, et al. Journal article Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article Biomarkers for Personalizing IBD Therapy: The Quest Continues (2024) Atreya R, Neurath M Journal article, Review article Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure (2024) Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, et al. Journal article